Reliability of core needle biopsy for determining ER and HER2 status in breast cancer

Tim Dekker(Leiden University Medical Center), Judith R. Kroep(Leiden University Medical Center)
Annals of Oncology
December 5, 2012
10.1093/annonc/mds599
Cited by 78

Related Papers

Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
|European Journal of Cancer|2011|464
The Iontophoresis of Fentanyl Citrate in Humans 
|Anesthesiology|1995|80
Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach
|Breast Cancer Research|2012|57